Cytodyn Inc. (QB) Stock Price - CYDY

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Cytodyn Inc. (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.02 1.94% 1.05 1.09 1.01 1.08 1.03 15:59:10
Bid Price Ask Price Spread Spread % News
1.04 1.05 0.01 0.95% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
474 1,859,010 $ 1.0386 $ 1,930,836 1,945,317 0.0552 - 1.18
Last Trade Time Type Quantity Stock Price Currency
16:08:48 average 172,481 $ 1.0143 USD

Cytodyn Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 455.47M 433.78M $ -50.15M - - 331.64M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.72M $ - 0.00% - -

more financials information »

Cytodyn Inc. (QB) News

Loading Messages....

Latest CYDY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.9341.170.8551.072,760,7140.11612.42%
1 Month0.653741.180.500.89962193,745,3090.3962660.61%
3 Months0.341.180.2610.66726352,039,4270.71208.82%
6 Months0.45991.180.2610.59927251,169,4540.5901128.31%
1 Year0.511.180.05520.5626605829,9530.54105.88%
3 Years0.771.180.05520.5765085437,1150.2836.36%
5 Years0.991.570.05520.6528471335,1180.066.06%

Cytodyn Inc. (QB) Description

CytoDyn is a publicly traded biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses. CytoDyn's lead product candidate, PRO 140, has the potential to drive groundbreaking advancements in developing the next generation of HIV treatments.


Your Recent History
USOTC
CYDY
Cytodyn In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.